The UK, the UPC, and the EPO: Building a Coordinated European Litigation Strategy

Discuss the strategic deployment of European litigation venues for US pharma companies, including the UK High Court litigation, UPC proceedings and EPO oppositions, and compare the impacts on injunction risk, cost exposure, and global settlement dynamics.